These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 8464032

  • 1. Design, synthesis, and pharmacology of 3-substituted sodium azulene-1-sulfonates and related compounds: non-prostanoid thromboxane A2 receptor antagonists.
    Tomiyama T, Yokota M, Wakabayashi S, Kosakai K, Yanagisawa T.
    J Med Chem; 1993 Apr 02; 36(7):791-800. PubMed ID: 8464032
    [Abstract] [Full Text] [Related]

  • 2. Pharmacologic properties of KT2-962 (6-isopropyl-3-[4-(p- chlorobenzenesulfonylamino)-butyl]-azulene-1-sulfonic acid sodium salt); a new TXA2/prostaglandin endoperoxide receptor antagonist.
    Kosakai K, Wakabayashi S, Sato T, Mochizuki S, Tomiyama A, Zhou Q, Satake N, Shibata S.
    J Cardiovasc Pharmacol; 1993 Mar 02; 21(3):441-7. PubMed ID: 7681506
    [Abstract] [Full Text] [Related]

  • 3. Thromboxane receptor antagonism combined with thromboxane synthase inhibition. 2. Synthesis and biological activity of 8-(benzenesulfonamido)-7-(3-pyridinyl)octaonic acid and related compounds.
    Main AJ, Goldstein R, Cohen DS, Furness P, Lee W.
    J Med Chem; 1992 Nov 13; 35(23):4362-5. PubMed ID: 1447736
    [Abstract] [Full Text] [Related]

  • 4. Antiaggregant and antivasospastic properties of the new thromboxane A2 receptor antagonist sodium 4-[[1-[[[(4-chlorophenyl)sulfonyl]amino]methyl]cyclopentyl] methyl]benzeneacetate.
    Lardy C, Rousselot C, Chavernac G, Depin JC, Guerrier D.
    Arzneimittelforschung; 1994 Nov 13; 44(11):1196-202. PubMed ID: 7848331
    [Abstract] [Full Text] [Related]

  • 5. Synthesis and thromboxane A2 antagonistic activity of [[1-aryl(or benzyl)-1-(benzenesulfonamido)methyl]phenyl]alkanoic acid derivatives.
    Sakurai S, Ogawa N, Suzuki T, Kato K, Ohashi T, Yasuda S, Kato H, Ito Y.
    Chem Pharm Bull (Tokyo); 1996 Apr 13; 44(4):765-77. PubMed ID: 8681409
    [Abstract] [Full Text] [Related]

  • 6. Pharmacological characterization of potent, long-acting thromboxane receptor antagonists, SQ 33,261 and SQ 33,552.
    Harris DN, Michel IM, Goldenberg HJ, Hartl KS, Allen GT, Steinbacher TE, Schumacher WA, Han WC, Hall SE, Floyd DM.
    J Pharmacol Exp Ther; 1992 Apr 13; 261(1):131-7. PubMed ID: 1532833
    [Abstract] [Full Text] [Related]

  • 7. Azulene derivatives as TXA2/PGH2 receptor antagonists--II. Synthesis and biological activity of 6-mono- and 6-dihydroxylated-isopropylazulenes.
    Yokota M, Uchibori S, Hayashi H, Koyama R, Kosakai K, Wakabayashi S, Tomiyama T.
    Bioorg Med Chem; 1996 Apr 13; 4(4):575-91. PubMed ID: 8735846
    [Abstract] [Full Text] [Related]

  • 8. Thromboxane A2-mediated shape change: independent of Gq-phospholipase C--Ca2+ pathway in rabbit platelets.
    Ohkubo S, Nakahata N, Ohizumi Y.
    Br J Pharmacol; 1996 Mar 13; 117(6):1095-104. PubMed ID: 8882602
    [Abstract] [Full Text] [Related]

  • 9. Antiplatelet effects of the novel thromboxane A2 receptor antagonist sodium (E)-11-[2-(5,6-dimethyl-1-benzimidazolyl)-ethylidene]-6,11- dihydrodibenz[b,e] oxepine-2-carboxylate monohydrate.
    Karasawa A, Kawakage M, Shirakura S, Higo K, Kubo K, Ohshima E, Obase H.
    Arzneimittelforschung; 1991 Dec 13; 41(12):1230-6. PubMed ID: 1840011
    [Abstract] [Full Text] [Related]

  • 10. Labeling of human platelet plasma membrane thromboxane A2/prostaglandin H2 receptors using SQB, a novel biotinylated receptor probe.
    Komiotis D, Wencel-Drake JD, Dieter JP, Lim CT, Le Breton GC.
    Biochem Pharmacol; 1996 Sep 13; 52(5):763-70. PubMed ID: 8765474
    [Abstract] [Full Text] [Related]

  • 11. Non-prostanoid thromboxane A2 receptor antagonists with a dibenzoxepin ring system. 2.
    Ohshima E, Takami H, Sato H, Mohri S, Obase H, Miki I, Ishii A, Shirakura S, Karasawa A, Kubo K.
    J Med Chem; 1992 Sep 04; 35(18):3402-13. PubMed ID: 1388208
    [Abstract] [Full Text] [Related]

  • 12. Pharmacological characterization of cinnamophilin, a novel dual inhibitor of thromboxane synthase and thromboxane A2 receptor.
    Yu SM, Wu TS, Teng CM.
    Br J Pharmacol; 1994 Mar 04; 111(3):906-12. PubMed ID: 8019768
    [Abstract] [Full Text] [Related]

  • 13. Actions of the novel thromboxane A2 receptor antagonist sodium (E)-11-[2-(5,6-dimethyl-1-benzimidazolyl)-ethylidene]-6,11- dihydrodibenz[b,e]oxepine-1-carboxylate monohydrate on smooth muscle preparations.
    Karasawa A, Shirakura S, Higo K, Kubo K.
    Arzneimittelforschung; 1991 Dec 04; 41(12):1237-41. PubMed ID: 1815522
    [Abstract] [Full Text] [Related]

  • 14. Agents combining thromboxane receptor antagonism with thromboxane synthase inhibition: [[[2-(1H-imidazol-1-yl)ethylidene]amino]oxy]alkanoic acids.
    Cozzi P, Giordani A, Menichincheri M, Pillan A, Pinciroli V, Rossi A, Tonani R, Volpi D, Tamburin M, Ferrario R.
    J Med Chem; 1994 Oct 14; 37(21):3588-604. PubMed ID: 7932586
    [Abstract] [Full Text] [Related]

  • 15. The thromboxane A2/prostaglandin endoperoxide receptor antagonist activity of CV-4151, a thromboxane A2 synthetase inhibitor.
    Imura Y, Terashita Z, Shibouta Y, Nishikawa K.
    Eur J Pharmacol; 1988 Mar 15; 147(3):359-65. PubMed ID: 2967770
    [Abstract] [Full Text] [Related]

  • 16. Stereoselective synthesis and thromboxane A2 (TXA2) receptor antagonistic activity of optically active phenol derivatives.
    Fukumoto S, Terashita Z, Ashida Y, Terao S, Shiraishi M.
    Chem Pharm Bull (Tokyo); 1996 Apr 15; 44(4):749-55. PubMed ID: 8681407
    [Abstract] [Full Text] [Related]

  • 17. Novel angiotensin II AT(1) receptor antagonist irbesartan prevents thromboxane A(2)-induced vasoconstriction in canine coronary arteries and human platelet aggregation.
    Li P, Fukuhara M, Diz DI, Ferrario CM, Brosnihan KB.
    J Pharmacol Exp Ther; 2000 Jan 15; 292(1):238-46. PubMed ID: 10604953
    [Abstract] [Full Text] [Related]

  • 18. Synthesis and biological activity of 1-phenylsulfonyl-4-phenylsulfonylaminopyrrolidine derivatives as thromboxane a(2) receptor antagonists.
    Marusawa H, Setoi H, Sawada A, Kuroda A, Seki J, Motoyama Y, Tanaka H.
    Bioorg Med Chem; 2002 May 15; 10(5):1399-415. PubMed ID: 11886803
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Heterogeneity of prostaglandin H2/thromboxane A2 receptors: distinct subtypes mediate vascular smooth muscle contraction and platelet aggregation.
    Furci L, Fitzgerald DJ, Fitzgerald GA.
    J Pharmacol Exp Ther; 1991 Jul 01; 258(1):74-81. PubMed ID: 1830100
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.